Blocker

FDA denies approval to Forest LabsForest Laboratories, Inc. (NYSE: FRX) announced today that the U.S. Food and Drug Administration (FDA) did not approve the additional indication for Bystolic(R) (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the... Read More

Enzymicals acquires PLE rights from EvonikThe Enzymicals AG gained proprietary rights for the well-known recombinant pig liver esterases (PLE) from Evonik AG in Hanau. The intellectual property (IP) covers a range of PLE isoenzymes for hydrolysis of several compounds such as esters of secondary... Read More

FDA approves Bayer ED med; GSK, Merck to marketGlaxoSmithKline (NYSE: GSK) and Merck & Co., Inc. (NYSE: MRK) announced today the U.S. Food and Drug Administration (FDA) has approved STAXYN™ (vardenafil HCI), an orally disintegrating tablet indicated for the treatment of erectile dysfunction (ED).... Read More